Federal Register Notice: FDA is making available a draft guidance for industry, Label Comprehension Studies for Nonprescription Drug Products. It provides recommendations on designing label comprehension studies, which can be used to assess the extent to which consumers understand the information conveyed by proposed nonprescription drug product labeling and then apply that information when making hypothetical drug product use decisions. To download this guidance, click here. To view this notice, click here.